CD5 positive follicular lymphomas: A diagnostic dilemma in a resource restricted laboratory setting

  • Sakthi Sankari Shanmuga Department of Pathology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamilnadu, India, 641004
  • Arjunan Angaraju Department of Pathology, Coimbatore Medical college, Coimbatore, Tamilnadu, India
  • Bhuvaneswari M Ganesan Department of Pathology, Coimbatore Medical college, Coimbatore, Tamilnadu, India
  • Sindhuja Ramalingam Department of Pathology, Thirunelveli Medical college, Tamilnadu, India
  • Rajeswari Thivya Dhanabalan Department of Pathology, Karpaga Vinayaga Medical College, Kanchipuram, Tamilnadu, India
Keywords: Follicular lymphoma, CD 5 positive, indolent lymphomas, B cell NHL, Immunohistochemistry

Abstract

Background: Follicular lymphoma is an indolent B Non Hodgkin lymphoma which has a characteristic follicular growth pattern and immunohistochemical expression. The neoplastic cells express CD20, CD10, BCL2 and are negative for CD5, CD23 and Cyclin D1. CD5 is a useful marker in the differentiation of various B cell lymphomas. Small cell lymphoma and mantle cell lymphoma express CD5. Some of the follicular lymphomas  express CD5 which results in diagnostic confusion.Methods: 52 cases of lymphoma were diagnosed over a period of 2 years in a tertiary care centre in south India. Among these, 9 cases were diagnosed as follicular lymphoma based on the morphological abd immunohistochemical study. A panel of antibodies were chosen based on the morphological diagnosis.The panel used for small cell lymphomas include  CD20, CD3, CD5 CD23, Cyclin D1, CD10, BCL2 and Ki67.Result: Of the nine cases of follicular lymphoma, three were CD5 positive. Two showed bone marrow involvement. There was no significant morphological difference between CD5 positive and CD5 negative follicular lymphoma.Conclusion: The expression of CD5 by follicular lymphomas  could be problematic when the follicular lymphoma as such lacks its characteristic follicular pattern and there are no molecular studies available. Eventhough rare , follicular lymphoma is to be considered in the differential diagnosis of CD5 positive follicular lymphomas. DOI: 10.21276/APALM.1364

Author Biography

Sakthi Sankari Shanmuga, Department of Pathology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamilnadu, India, 641004
Pathology, Assistant Professor

References

1 Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J,Vardiman JW (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC: Lyon, 2008; 220–226.
2. Horsman DE, Gascoyne RD, Coupland RW et al. Comparison of cytogenetic analysis, southern analysis,and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma. Am J Clin Pathol 1995; 103:472–478
3. Stamatopoulos K, Kosmas C, Belessi C, et al. Molecular insights into the immunopathogenesis of follicular lymphoma. Immunol Today. 2000; 21:298-305.
4. Dogan A, Bagdi E, Munson P, et al. CD10 and bcl-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol. 2000; 24:846-852.
5. Dorfman DM, Shahsafaei A. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections. Mod Pathol. 1997; 10:859–863.
6. Yin CC, Lin P, Carney DA et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein. Am J Clin Pathol. 2005; 123: 594–602.
7. Leon ED, Alkan S, Huang JC, et al. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin’s lymphomas of small lymphocytes. Mod Pathol. 1998; 11:1046-1051.
9. Sundeen JT, Longo DL, Jaffe ES. CD5 expression in B-cell small lymphocytic malignancies: correlations with clinical presentation and sites of disease. Am J Surg Pathol. 1992; 16:130-137.
10. Dong HY, Gorczyca W, Liu Z et al. B-cell lymphomas with coexpression of CD5 and CD10. Am J Clin Pathol. 2003; 119:218–230.
11. Sekiguchi Y, Imai H, Wakabayashi M et al. CD5- positive follicular lymphoma: a case report and literature review. Intern Med. 2011; 50:899–904.
12. Mayson E, Saverimuttu J, Cartwright K. CD5-positive follicular lymphoma: prognostic significance of this aberrant marker? Intern Med J. 2014; 44:417–422.
13. Takata K, Miyata-Takata T, Sato Y, Yoshino T. Pathology of Follicular Lymphoma. J Clin Exp Hematop. 2014; 54(1): 3-9.
14. Fouad-Younes S, Beck A, Lossos IS, et al. Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the Detection of the Interfollicular and Diffuse
Components. Am J Surg Pathol. 2010; 34(9): 1266–76.
15. Rizzo K, Nassiri M. DiagnosticWorkup of Small B cell Lymphomas: A Laboratory Perspective. Hindawi Publishing Corporation Lymphoma. 2012;
16. Barry TS, Jaffe ES. CD5+ Follicular Lymphoma A Clinicopathologic Study of Three Cases. Am J Clin Pathol 2002; 118:589-598.
17. Yu Li, Shimin Hu, Zhuang Zuo, Ming Hong. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases. Modern Pathology 2015;28, 787–798.
Published
2017-12-10
Section
Original Article